Share Price and Basic Stock Data
Last Updated: January 29, 2026, 11:08 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Sagar Cements Ltd operates within the cement industry, a sector characterized by cyclical demand influenced by infrastructure and real estate developments. The company reported a revenue of ₹2,230 Cr for the fiscal year ending March 2023, reflecting a significant increase from ₹1,597 Cr in the previous fiscal year. This upward trajectory continued into FY 2024, where revenue rose to ₹2,505 Cr, although it is projected to decline to ₹2,258 Cr in FY 2025. Quarterly sales figures for FY 2024 indicated a robust performance, peaking at ₹709 Cr by March 2024. However, subsequent quarters showed fluctuations, with sales decreasing to ₹475 Cr by September 2024. Sagar Cements’ ability to navigate these revenue fluctuations is critical for maintaining market position and investor confidence, especially given the cyclical nature of the cement market.
Profitability and Efficiency Metrics
The profitability of Sagar Cements has been under pressure, as evidenced by a net profit of ₹-164 Cr as of the latest reporting period. The operating profit margin (OPM) stood at a modest 9% in the latest quarter, with fluctuations throughout FY 2024 and FY 2025, peaking at 18% in June 2025. The company’s interest coverage ratio (ICR) remained below 1 at 0.86x, indicating potential challenges in meeting interest obligations. This is compounded by a negative return on capital employed (ROCE) of -2% in FY 2025, highlighting inefficiencies in capital allocation. The company recorded negative net profit margins, which reached -9.59% in FY 2025, underscoring the need for strategic operational improvements to enhance profitability and efficiency.
Balance Sheet Strength and Financial Ratios
Sagar Cements’ balance sheet reflects a total market capitalization of ₹2,511 Cr, with total borrowings amounting to ₹1,640 Cr. The company maintains a reserve of ₹1,656 Cr, which indicates a reasonable buffer against financial distress. The debt-to-equity ratio stands at 0.82x, suggesting a moderate level of leverage compared to industry standards. However, the current ratio of 0.58x indicates liquidity concerns, as it falls below the ideal threshold of 1, indicating potential difficulty in covering short-term liabilities. The book value per share decreased to ₹131.81 in March 2025 from ₹154.53 in March 2024, suggesting erosion of shareholder value. Overall, while the company possesses adequate reserves, its liquidity and profitability metrics warrant careful scrutiny.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Sagar Cements reflects a diversified ownership structure, with promoters holding 48.33%, foreign institutional investors (FIIs) at 2.84%, domestic institutional investors (DIIs) at 17.39%, and the public holding 31.42%. The increase in promoter holdings from 45.20% in March 2023 to the current level demonstrates a commitment to the company amid challenging market conditions. However, the decline in FIIs from 3.99% in December 2022 to the current 2.84% may signal reduced confidence among international investors. The total number of shareholders has decreased to 31,977, indicating a potential decline in retail interest. This mixed sentiment could affect future capital raising efforts and market perception of Sagar Cements.
Outlook, Risks, and Final Insight
The outlook for Sagar Cements hinges on its ability to stabilize revenue and improve profitability. Key strengths include a solid reserve base and a commitment from promoters, which can provide stability during turbulent market phases. However, significant risks remain, including liquidity issues reflected in the current ratio and declining profitability metrics. Additionally, the company’s reliance on debt could pose challenges if market conditions worsen. Stakeholders should remain vigilant regarding operational efficiencies and strategic initiatives to enhance margins. If Sagar Cements successfully implements cost-control measures and capitalizes on infrastructure growth in India, it may recover and regain investor confidence. Conversely, failure to address these operational challenges may lead to continued financial strain and further erosion of market position.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Bheema Cements Ltd | 52.7 Cr. | 16.2 | 19.5/16.2 | 0.60 | 0.00 % | 13.1 % | 108 % | 10.0 | |
| UltraTech Cement Ltd | 3,71,443 Cr. | 12,605 | 13,102/10,048 | 47.8 | 2,444 | 0.61 % | 10.9 % | 9.29 % | 10.0 |
| The Ramco Cements Ltd | 25,184 Cr. | 1,066 | 1,209/788 | 131 | 322 | 0.19 % | 4.83 % | 1.56 % | 1.00 |
| The India Cements Ltd | 13,662 Cr. | 441 | 490/239 | 325 | 0.00 % | 5.49 % | 8.83 % | 10.0 | |
| Star Cement Ltd | 8,742 Cr. | 216 | 309/197 | 28.9 | 74.4 | 0.46 % | 8.39 % | 6.05 % | 1.00 |
| Industry Average | 38,399.38 Cr | 1,940.56 | 36.33 | 573.47 | 0.57% | 8.79% | 85.81% | 7.13 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 475 | 576 | 622 | 540 | 587 | 669 | 709 | 561 | 475 | 564 | 658 | 671 | 602 |
| Expenses | 469 | 528 | 583 | 509 | 527 | 582 | 641 | 514 | 455 | 526 | 621 | 549 | 551 |
| Operating Profit | 6 | 48 | 39 | 30 | 60 | 87 | 68 | 47 | 20 | 38 | 37 | 121 | 51 |
| OPM % | 1% | 8% | 6% | 6% | 10% | 13% | 10% | 8% | 4% | 7% | 6% | 18% | 9% |
| Other Income | 15 | 14 | 181 | 4 | 18 | 4 | 44 | 8 | 5 | 5 | -24 | 4 | 4 |
| Interest | 50 | 51 | 52 | 44 | 47 | 49 | 45 | 46 | 46 | 48 | 47 | 47 | 46 |
| Depreciation | 38 | 40 | 42 | 50 | 51 | 57 | 56 | 56 | 58 | 59 | 58 | 55 | 56 |
| Profit before tax | -68 | -29 | 126 | -59 | -20 | -15 | 10 | -48 | -79 | -64 | -93 | 24 | -47 |
| Tax % | -36% | -19% | 30% | -29% | -48% | -28% | -13% | -32% | -28% | -15% | -21% | 69% | -5% |
| Net Profit | -44 | -24 | 88 | -42 | -11 | -10 | 12 | -32 | -57 | -54 | -73 | 7 | -44 |
| EPS in Rs | -2.80 | -1.42 | 6.92 | -3.05 | -0.64 | -0.62 | 1.01 | -2.17 | -4.25 | -4.21 | -5.41 | 0.09 | -3.24 |
Last Updated: December 29, 2025, 7:35 am
Below is a detailed analysis of the quarterly data for Sagar Cements Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 602.00 Cr.. The value appears to be declining and may need further review. It has decreased from 671.00 Cr. (Jun 2025) to 602.00 Cr., marking a decrease of 69.00 Cr..
- For Expenses, as of Sep 2025, the value is 551.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 549.00 Cr. (Jun 2025) to 551.00 Cr., marking an increase of 2.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 51.00 Cr.. The value appears to be declining and may need further review. It has decreased from 121.00 Cr. (Jun 2025) to 51.00 Cr., marking a decrease of 70.00 Cr..
- For OPM %, as of Sep 2025, the value is 9.00%. The value appears to be declining and may need further review. It has decreased from 18.00% (Jun 2025) to 9.00%, marking a decrease of 9.00%.
- For Other Income, as of Sep 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 4.00 Cr..
- For Interest, as of Sep 2025, the value is 46.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 47.00 Cr. (Jun 2025) to 46.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 56.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 55.00 Cr. (Jun 2025) to 56.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is -47.00 Cr.. The value appears to be declining and may need further review. It has decreased from 24.00 Cr. (Jun 2025) to -47.00 Cr., marking a decrease of 71.00 Cr..
- For Tax %, as of Sep 2025, the value is -5.00%. The value appears to be improving (decreasing) as expected. It has decreased from 69.00% (Jun 2025) to -5.00%, marking a decrease of 74.00%.
- For Net Profit, as of Sep 2025, the value is -44.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Jun 2025) to -44.00 Cr., marking a decrease of 51.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is -3.24. The value appears to be declining and may need further review. It has decreased from 0.09 (Jun 2025) to -3.24, marking a decrease of 3.33.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:42 am
| Metric | Mar 2009 | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 270 | 425 | 753 | 814 | 1,038 | 1,218 | 1,175 | 1,371 | 1,597 | 2,230 | 2,505 | 2,258 | 2,494 |
| Expenses | 205 | 340 | 630 | 703 | 887 | 1,068 | 990 | 971 | 1,321 | 2,076 | 2,258 | 2,116 | 2,247 |
| Operating Profit | 65 | 85 | 123 | 110 | 151 | 150 | 186 | 400 | 276 | 153 | 247 | 141 | 247 |
| OPM % | 24% | 20% | 16% | 14% | 15% | 12% | 16% | 29% | 17% | 7% | 10% | 6% | 10% |
| Other Income | 1 | 6 | 4 | 4 | 7 | 2 | 4 | 8 | 13 | 223 | 68 | -6 | -10 |
| Interest | 16 | 30 | 42 | 62 | 59 | 63 | 61 | 47 | 92 | 202 | 185 | 188 | 189 |
| Depreciation | 21 | 29 | 35 | 48 | 54 | 66 | 79 | 81 | 93 | 156 | 214 | 231 | 227 |
| Profit before tax | 29 | 32 | 51 | 4 | 46 | 23 | 50 | 281 | 104 | 18 | -84 | -284 | -179 |
| Tax % | 32% | 37% | 13% | 193% | 42% | 41% | 47% | 34% | 43% | 48% | -38% | -24% | |
| Net Profit | 19 | 20 | 44 | -4 | 26 | 14 | 27 | 186 | 59 | 10 | -52 | -217 | -164 |
| EPS in Rs | 2.54 | 2.58 | 5.09 | -0.38 | 2.57 | 1.33 | 2.40 | 15.88 | 5.89 | 2.31 | -3.32 | -16.05 | -12.77 |
| Dividend Payout % | 29% | 24% | 20% | -78% | 31% | 38% | 21% | 8% | 12% | 30% | -21% | 0% |
YoY Net Profit Growth
| Year | 2009-2010 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 5.26% | -109.09% | 750.00% | -46.15% | 92.86% | 588.89% | -68.28% | -83.05% | -620.00% | -317.31% |
| Change in YoY Net Profit Growth (%) | 0.00% | -114.35% | 859.09% | -796.15% | 139.01% | 496.03% | -657.17% | -14.77% | -536.95% | 302.69% |
Sagar Cements Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2009-2010 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 12% |
| TTM: | -6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -254% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 26% |
| 3 Years: | 12% |
| 1 Year: | 26% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 0% |
| 3 Years: | -4% |
| Last Year: | -10% |
Last Updated: September 5, 2025, 1:15 pm
Balance Sheet
Last Updated: January 7, 2026, 4:20 pm
| Month | Mar 2009 | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 15 | 15 | 17 | 20 | 20 | 20 | 22 | 24 | 24 | 26 | 26 | 26 | 26 |
| Reserves | 184 | 198 | 532 | 743 | 759 | 823 | 944 | 1,167 | 1,232 | 1,968 | 1,915 | 1,697 | 1,656 |
| Borrowings | 252 | 231 | 434 | 487 | 478 | 509 | 491 | 809 | 1,510 | 1,478 | 1,444 | 1,448 | 1,640 |
| Other Liabilities | 95 | 122 | 264 | 259 | 281 | 375 | 460 | 547 | 583 | 621 | 863 | 950 | 1,074 |
| Total Liabilities | 545 | 565 | 1,247 | 1,509 | 1,539 | 1,728 | 1,918 | 2,546 | 3,349 | 4,093 | 4,248 | 4,121 | 4,396 |
| Fixed Assets | 382 | 378 | 957 | 1,001 | 1,053 | 1,244 | 1,384 | 1,301 | 2,048 | 3,168 | 3,250 | 3,109 | 3,041 |
| CWIP | 18 | 10 | 15 | 55 | 125 | 110 | 108 | 517 | 100 | 99 | 15 | 123 | 316 |
| Investments | 15 | 38 | 0 | 0 | 0 | 0 | 0 | 0 | 315 | 0 | 0 | 0 | 0 |
| Other Assets | 130 | 139 | 274 | 452 | 361 | 374 | 426 | 727 | 886 | 826 | 983 | 889 | 1,039 |
| Total Assets | 545 | 565 | 1,247 | 1,509 | 1,539 | 1,728 | 1,918 | 2,546 | 3,349 | 4,093 | 4,248 | 4,121 | 4,396 |
Below is a detailed analysis of the balance sheet data for Sagar Cements Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 26.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,656.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,697.00 Cr. (Mar 2025) to 1,656.00 Cr., marking a decrease of 41.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,640.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,448.00 Cr. (Mar 2025) to 1,640.00 Cr., marking an increase of 192.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,074.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 950.00 Cr. (Mar 2025) to 1,074.00 Cr., marking an increase of 124.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 4,396.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,121.00 Cr. (Mar 2025) to 4,396.00 Cr., marking an increase of 275.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 3,041.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,109.00 Cr. (Mar 2025) to 3,041.00 Cr., marking a decrease of 68.00 Cr..
- For CWIP, as of Sep 2025, the value is 316.00 Cr.. The value appears strong and on an upward trend. It has increased from 123.00 Cr. (Mar 2025) to 316.00 Cr., marking an increase of 193.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,039.00 Cr.. The value appears strong and on an upward trend. It has increased from 889.00 Cr. (Mar 2025) to 1,039.00 Cr., marking an increase of 150.00 Cr..
- For Total Assets, as of Sep 2025, the value is 4,396.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,121.00 Cr. (Mar 2025) to 4,396.00 Cr., marking an increase of 275.00 Cr..
Notably, the Reserves (1,656.00 Cr.) exceed the Borrowings (1,640.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2009 | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2009 | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -187.00 | -146.00 | -311.00 | -377.00 | -327.00 | -359.00 | -305.00 | -409.00 | 275.00 | 152.00 | 246.00 | 140.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2009 | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 34 | 36 | 39 | 36 | 33 | 35 | 42 | 27 | 28 | 22 | 30 | 33 |
| Inventory Days | 200 | 209 | 241 | 386 | 239 | 222 | 186 | 189 | 338 | 241 | 273 | 232 |
| Days Payable | 136 | 150 | 353 | 516 | 344 | 312 | 358 | 349 | 358 | 267 | 460 | 490 |
| Cash Conversion Cycle | 97 | 95 | -73 | -95 | -73 | -55 | -130 | -133 | 7 | -4 | -157 | -225 |
| Working Capital Days | 61 | 40 | -57 | -46 | -46 | -59 | -61 | -2 | -45 | -36 | -59 | -108 |
| ROCE % | 12% | 14% | 6% | 8% | 7% | 8% | 18% | 8% | 6% | 1% | -2% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Multi Asset Allocation Fund | 3,338,867 | 0.55 | 71.6 | 2,321,227 | 2025-12-28 21:50:56 | 43.84% |
| ICICI Prudential Commodities Fund | 2,068,421 | 1.3 | 44.35 | 1,460,012 | 2026-01-26 02:55:23 | 41.67% |
| ICICI Prudential Smallcap Fund | 1,598,527 | 0.41 | 34.28 | 2,691,812 | 2025-12-08 00:43:19 | -40.62% |
| HDFC Multi Cap Fund | 1,473,276 | 0.16 | 31.59 | N/A | N/A | N/A |
| ICICI Prudential Infrastructure Fund | 432,619 | 0.11 | 9.28 | N/A | N/A | N/A |
| SBI Comma Fund | 366,286 | 0.91 | 7.85 | N/A | N/A | N/A |
| ICICI Prudential Manufacturing Fund | 362,364 | 0.12 | 7.77 | N/A | N/A | N/A |
| ICICI Prudential Retirement Fund - Pure Equity | 121,228 | 0.16 | 2.6 | N/A | N/A | N/A |
| ICICI Prudential Regular Savings Fund | 98,558 | 0.06 | 2.11 | N/A | N/A | N/A |
| ICICI Prudential Retirement Fund - Hybrid Conservative | 3,281 | 0.08 | 0.07 | 60,925 | 2025-12-28 08:00:57 | -94.61% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 10.00 |
| Basic EPS (Rs.) | -16.58 | -3.98 | 0.66 | 5.03 | 80.24 |
| Diluted EPS (Rs.) | -16.58 | -3.98 | 0.66 | 5.03 | 80.24 |
| Cash EPS (Rs.) | 1.08 | 12.40 | 12.57 | 12.92 | 113.26 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 131.81 | 154.53 | 129.22 | 111.44 | 535.34 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 131.81 | 154.53 | 129.22 | 111.44 | 535.34 |
| Revenue From Operations / Share (Rs.) | 172.73 | 191.63 | 170.58 | 135.90 | 583.54 |
| PBDIT / Share (Rs.) | 12.43 | 22.96 | 28.76 | 24.61 | 173.71 |
| PBIT / Share (Rs.) | -5.22 | 6.57 | 16.84 | 16.72 | 139.43 |
| PBT / Share (Rs.) | -21.69 | -6.44 | 1.41 | 8.85 | 119.62 |
| Net Profit / Share (Rs.) | -16.58 | -3.98 | 0.65 | 5.03 | 78.98 |
| NP After MI And SOA / Share (Rs.) | -16.05 | -3.32 | 2.22 | 5.88 | 79.16 |
| PBDIT Margin (%) | 7.19 | 11.97 | 16.85 | 18.10 | 29.76 |
| PBIT Margin (%) | -3.02 | 3.43 | 9.87 | 12.30 | 23.89 |
| PBT Margin (%) | -12.55 | -3.35 | 0.82 | 6.51 | 20.49 |
| Net Profit Margin (%) | -9.59 | -2.07 | 0.38 | 3.70 | 13.53 |
| NP After MI And SOA Margin (%) | -9.29 | -1.73 | 1.30 | 4.33 | 13.56 |
| Return on Networth / Equity (%) | -12.17 | -2.23 | 1.77 | 5.50 | 15.44 |
| Return on Capital Employeed (%) | -2.29 | 2.56 | 7.20 | 7.50 | 15.91 |
| Return On Assets (%) | -5.02 | -0.99 | 0.75 | 2.05 | 7.22 |
| Long Term Debt / Equity (X) | 0.57 | 0.56 | 0.70 | 0.89 | 0.52 |
| Total Debt / Equity (X) | 0.82 | 0.74 | 0.89 | 1.20 | 0.61 |
| Asset Turnover Ratio (%) | 0.52 | 0.61 | 0.62 | 0.59 | 0.52 |
| Current Ratio (X) | 0.58 | 0.85 | 0.97 | 0.95 | 1.15 |
| Quick Ratio (X) | 0.35 | 0.55 | 0.62 | 0.67 | 0.90 |
| Inventory Turnover Ratio (X) | 7.77 | 1.59 | 1.59 | 1.72 | 1.46 |
| Dividend Payout Ratio (NP) (%) | -4.36 | -21.10 | 31.50 | 8.50 | 8.21 |
| Dividend Payout Ratio (CP) (%) | 43.65 | 5.35 | 4.95 | 3.63 | 5.73 |
| Earning Retention Ratio (%) | 104.36 | 121.10 | 68.50 | 91.50 | 91.79 |
| Cash Earning Retention Ratio (%) | 56.35 | 94.65 | 95.05 | 96.37 | 94.27 |
| Interest Coverage Ratio (X) | 0.86 | 1.62 | 1.86 | 3.13 | 8.77 |
| Interest Coverage Ratio (Post Tax) (X) | -0.01 | 0.63 | 1.04 | 1.64 | 4.99 |
| Enterprise Value (Cr.) | 3682.52 | 3981.14 | 3785.92 | 4295.75 | 2217.77 |
| EV / Net Operating Revenue (X) | 1.63 | 1.59 | 1.70 | 2.69 | 1.62 |
| EV / EBITDA (X) | 22.66 | 13.27 | 10.07 | 14.85 | 5.43 |
| MarketCap / Net Operating Revenue (X) | 1.04 | 1.09 | 1.11 | 1.82 | 1.22 |
| Retention Ratios (%) | 104.36 | 121.10 | 68.49 | 91.49 | 91.78 |
| Price / BV (X) | 1.36 | 1.40 | 1.51 | 2.31 | 1.39 |
| Price / Net Operating Revenue (X) | 1.04 | 1.09 | 1.11 | 1.82 | 1.22 |
| EarningsYield | -0.08 | -0.01 | 0.01 | 0.02 | 0.11 |
After reviewing the key financial ratios for Sagar Cements Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -16.58. This value is below the healthy minimum of 5. It has decreased from -3.98 (Mar 24) to -16.58, marking a decrease of 12.60.
- For Diluted EPS (Rs.), as of Mar 25, the value is -16.58. This value is below the healthy minimum of 5. It has decreased from -3.98 (Mar 24) to -16.58, marking a decrease of 12.60.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.08. This value is below the healthy minimum of 3. It has decreased from 12.40 (Mar 24) to 1.08, marking a decrease of 11.32.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 131.81. It has decreased from 154.53 (Mar 24) to 131.81, marking a decrease of 22.72.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 131.81. It has decreased from 154.53 (Mar 24) to 131.81, marking a decrease of 22.72.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 172.73. It has decreased from 191.63 (Mar 24) to 172.73, marking a decrease of 18.90.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 12.43. This value is within the healthy range. It has decreased from 22.96 (Mar 24) to 12.43, marking a decrease of 10.53.
- For PBIT / Share (Rs.), as of Mar 25, the value is -5.22. This value is below the healthy minimum of 0. It has decreased from 6.57 (Mar 24) to -5.22, marking a decrease of 11.79.
- For PBT / Share (Rs.), as of Mar 25, the value is -21.69. This value is below the healthy minimum of 0. It has decreased from -6.44 (Mar 24) to -21.69, marking a decrease of 15.25.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -16.58. This value is below the healthy minimum of 2. It has decreased from -3.98 (Mar 24) to -16.58, marking a decrease of 12.60.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -16.05. This value is below the healthy minimum of 2. It has decreased from -3.32 (Mar 24) to -16.05, marking a decrease of 12.73.
- For PBDIT Margin (%), as of Mar 25, the value is 7.19. This value is below the healthy minimum of 10. It has decreased from 11.97 (Mar 24) to 7.19, marking a decrease of 4.78.
- For PBIT Margin (%), as of Mar 25, the value is -3.02. This value is below the healthy minimum of 10. It has decreased from 3.43 (Mar 24) to -3.02, marking a decrease of 6.45.
- For PBT Margin (%), as of Mar 25, the value is -12.55. This value is below the healthy minimum of 10. It has decreased from -3.35 (Mar 24) to -12.55, marking a decrease of 9.20.
- For Net Profit Margin (%), as of Mar 25, the value is -9.59. This value is below the healthy minimum of 5. It has decreased from -2.07 (Mar 24) to -9.59, marking a decrease of 7.52.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -9.29. This value is below the healthy minimum of 8. It has decreased from -1.73 (Mar 24) to -9.29, marking a decrease of 7.56.
- For Return on Networth / Equity (%), as of Mar 25, the value is -12.17. This value is below the healthy minimum of 15. It has decreased from -2.23 (Mar 24) to -12.17, marking a decrease of 9.94.
- For Return on Capital Employeed (%), as of Mar 25, the value is -2.29. This value is below the healthy minimum of 10. It has decreased from 2.56 (Mar 24) to -2.29, marking a decrease of 4.85.
- For Return On Assets (%), as of Mar 25, the value is -5.02. This value is below the healthy minimum of 5. It has decreased from -0.99 (Mar 24) to -5.02, marking a decrease of 4.03.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.57. This value is within the healthy range. It has increased from 0.56 (Mar 24) to 0.57, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.82. This value is within the healthy range. It has increased from 0.74 (Mar 24) to 0.82, marking an increase of 0.08.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.52. It has decreased from 0.61 (Mar 24) to 0.52, marking a decrease of 0.09.
- For Current Ratio (X), as of Mar 25, the value is 0.58. This value is below the healthy minimum of 1.5. It has decreased from 0.85 (Mar 24) to 0.58, marking a decrease of 0.27.
- For Quick Ratio (X), as of Mar 25, the value is 0.35. This value is below the healthy minimum of 1. It has decreased from 0.55 (Mar 24) to 0.35, marking a decrease of 0.20.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.77. This value is within the healthy range. It has increased from 1.59 (Mar 24) to 7.77, marking an increase of 6.18.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is -4.36. This value is below the healthy minimum of 20. It has increased from -21.10 (Mar 24) to -4.36, marking an increase of 16.74.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 43.65. This value is within the healthy range. It has increased from 5.35 (Mar 24) to 43.65, marking an increase of 38.30.
- For Earning Retention Ratio (%), as of Mar 25, the value is 104.36. This value exceeds the healthy maximum of 70. It has decreased from 121.10 (Mar 24) to 104.36, marking a decrease of 16.74.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 56.35. This value is within the healthy range. It has decreased from 94.65 (Mar 24) to 56.35, marking a decrease of 38.30.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 3. It has decreased from 1.62 (Mar 24) to 0.86, marking a decrease of 0.76.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.01. This value is below the healthy minimum of 3. It has decreased from 0.63 (Mar 24) to -0.01, marking a decrease of 0.64.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,682.52. It has decreased from 3,981.14 (Mar 24) to 3,682.52, marking a decrease of 298.62.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.63. This value is within the healthy range. It has increased from 1.59 (Mar 24) to 1.63, marking an increase of 0.04.
- For EV / EBITDA (X), as of Mar 25, the value is 22.66. This value exceeds the healthy maximum of 15. It has increased from 13.27 (Mar 24) to 22.66, marking an increase of 9.39.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.04. This value is within the healthy range. It has decreased from 1.09 (Mar 24) to 1.04, marking a decrease of 0.05.
- For Retention Ratios (%), as of Mar 25, the value is 104.36. This value exceeds the healthy maximum of 70. It has decreased from 121.10 (Mar 24) to 104.36, marking a decrease of 16.74.
- For Price / BV (X), as of Mar 25, the value is 1.36. This value is within the healthy range. It has decreased from 1.40 (Mar 24) to 1.36, marking a decrease of 0.04.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.04. This value is within the healthy range. It has decreased from 1.09 (Mar 24) to 1.04, marking a decrease of 0.05.
- For EarningsYield, as of Mar 25, the value is -0.08. This value is below the healthy minimum of 5. It has decreased from -0.01 (Mar 24) to -0.08, marking a decrease of 0.07.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Sagar Cements Ltd:
- Net Profit Margin: -9.59%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -2.29% (Industry Average ROCE: 8.79%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -12.17% (Industry Average ROE: 85.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -0.01
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.35
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 36.33)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.82
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -9.59%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Cement | Plot No. 111, Hyderabad Telangana 500033 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. K V Vishnu Raju | Chairman & Ind.Director |
| Dr. S Anand Reddy | Managing Director |
| Mr. S Sreekanth Reddy | Joint Managing Director |
| Mrs. S Rachana | Non Executive Director |
| Mrs. O Rekha | Independent Director |
| Mr. Ravichandran Rajagopal | Independent Director |
| Mr. Madhavan Ganesan | Nominee Director |
| Mrs. N Sudha Rani | Nominee Director |
| Mr. Jens Van Nieuwenborgh | Nominee Director |
FAQ
What is the intrinsic value of Sagar Cements Ltd?
Sagar Cements Ltd's intrinsic value (as of 29 January 2026) is ₹89.64 which is 53.55% lower the current market price of ₹193.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹2,521 Cr. market cap, FY2025-2026 high/low of ₹300/155, reserves of ₹1,656 Cr, and liabilities of ₹4,396 Cr.
What is the Market Cap of Sagar Cements Ltd?
The Market Cap of Sagar Cements Ltd is 2,521 Cr..
What is the current Stock Price of Sagar Cements Ltd as on 29 January 2026?
The current stock price of Sagar Cements Ltd as on 29 January 2026 is ₹193.
What is the High / Low of Sagar Cements Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Sagar Cements Ltd stocks is ₹300/155.
What is the Stock P/E of Sagar Cements Ltd?
The Stock P/E of Sagar Cements Ltd is .
What is the Book Value of Sagar Cements Ltd?
The Book Value of Sagar Cements Ltd is 129.
What is the Dividend Yield of Sagar Cements Ltd?
The Dividend Yield of Sagar Cements Ltd is 0.00 %.
What is the ROCE of Sagar Cements Ltd?
The ROCE of Sagar Cements Ltd is 2.19 %.
What is the ROE of Sagar Cements Ltd?
The ROE of Sagar Cements Ltd is 10.3 %.
What is the Face Value of Sagar Cements Ltd?
The Face Value of Sagar Cements Ltd is 2.00.